FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801236435> ?p ?o ?g. }

• W2801236435 endingPage "32" @default.
• W2801236435 startingPage "24" @default.
• W2801236435 abstract "N2-(4-Amino-cyclohexyl)-9-cyclopentyl-N6-(6-furan-2-yl-pyridine-3-ylmethyl)-9H-purine-2,6-diamine (BP-14) and 2-(5-{[2-(4-amino-cyclohexylamino)-9-cyclopentyl-9H-purine-6-ylamino]-methyl}-pyridine-2-yl)-phenol (BP-20) are novel cyclin-dependent kinase inhibitors, structurally related to roscovitine, with significant biological activity. A simple, selective and sensitive liquid chromatography – tandem mass spectrometry method for determining them in rat plasma, using roscovitine as an internal standard, was developed and validated. Chromatographic separation was performed in reversed phase mode on Acquity BEH C18 column (100 × 2.1 mm, 1.7 μm) by gradient elution with mobile phases composed of 15 mM ammonium formate pH 4.0 and methanol at flow rate 0.25 mL/min at 40 °C. The analytes were detected based on their characteristic multiple reaction monitoring transitions in positive electrospray ionization mode m/z 473.07 > 157.93 for BP-14, m/z 499.62 > 184.2 for BP-20 and m/z 355.5 > 90.86 for internal standard. In plasma the method provided good linearity within the entire concentration range: 1–10,000 nmol/L (r2 = 0.9989) for BP-14 and 10–25,000 nmol/L (r2 = 0.9994) for BP-20; the limit of detection was 0.6 nmol/L for BP-14 and 6.1 nmol/L for BP-20. Validation was also performed in bile and urine. The results of validation fit within the acceptance limits following European Medicines Agency guidelines. The method was applied in a pharmacokinetic study of BP-14 and BP-20 in vivo in rats following intravenous and intraduodenal administration including plasma pharmacokinetics, tissue distribution and excretion (renal and biliary). Both compounds showed low bioavailability after intraduodenal administration (0.630 and 1.58% for BP-14 and BP-20, respectively). Distribution into all the analyzed tissues (brain, lungs, liver, kidney, spleen, muscle, adipose tissue) was observed 3 h after single dose administration, the highest and lowest concentrations being reached in the adipose tissue and brain, respectively. The biliary excretion of the parent BP-14 and BP-20 compounds accounted for 4.81% and 10.6% of the doses, respectively, and renal excretion for <0.5% in both cases. The obtained results represent pilot knowledge for further development of a new generation of compounds with strong anticancer activities." @default.
• W2801236435 created "2018-05-17" @default.
• W2801236435 creator A5005523010 @default.
• W2801236435 creator A5013089143 @default.
• W2801236435 creator A5013262483 @default.
• W2801236435 creator A5053576191 @default.
• W2801236435 creator A5073115394 @default.
• W2801236435 creator A5082008030 @default.
• W2801236435 creator A5085056121 @default.
• W2801236435 creator A5086891734 @default.
• W2801236435 date "2018-07-01" @default.
• W2801236435 modified "2023-10-13" @default.
• W2801236435 title "LC-MS/MS method for determination of cyclin-dependent kinase inhibitors, BP-14 and BP-20, and its application in pharmacokinetic study in rat" @default.
• W2801236435 cites W2031854329 @default.
• W2801236435 cites W2041959295 @default.
• W2801236435 cites W2055121108 @default.
• W2801236435 cites W2064850712 @default.
• W2801236435 cites W2071102601 @default.
• W2801236435 cites W2085961976 @default.
• W2801236435 cites W2089353165 @default.
• W2801236435 cites W2092285669 @default.
• W2801236435 cites W2109064685 @default.
• W2801236435 cites W2113662093 @default.
• W2801236435 cites W2131215120 @default.
• W2801236435 cites W2161583866 @default.
• W2801236435 cites W2169694429 @default.
• W2801236435 cites W2189238890 @default.
• W2801236435 cites W2281300910 @default.
• W2801236435 cites W2297912447 @default.
• W2801236435 cites W2329304300 @default.
• W2801236435 cites W2330667719 @default.
• W2801236435 cites W2606967831 @default.
• W2801236435 cites W2788171266 @default.
• W2801236435 cites W4255605666 @default.
• W2801236435 cites W4295718521 @default.
• W2801236435 doi "https://doi.org/10.1016/j.jchromb.2018.04.049" @default.
• W2801236435 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29753211" @default.
• W2801236435 hasPublicationYear "2018" @default.
• W2801236435 type Work @default.
• W2801236435 sameAs 2801236435 @default.
• W2801236435 citedByCount "0" @default.
• W2801236435 crossrefType "journal-article" @default.
• W2801236435 hasAuthorship W2801236435A5005523010 @default.
• W2801236435 hasAuthorship W2801236435A5013089143 @default.
• W2801236435 hasAuthorship W2801236435A5013262483 @default.
• W2801236435 hasAuthorship W2801236435A5053576191 @default.
• W2801236435 hasAuthorship W2801236435A5073115394 @default.
• W2801236435 hasAuthorship W2801236435A5082008030 @default.
• W2801236435 hasAuthorship W2801236435A5085056121 @default.
• W2801236435 hasAuthorship W2801236435A5086891734 @default.
• W2801236435 hasConcept C119128265 @default.
• W2801236435 hasConcept C162356407 @default.
• W2801236435 hasConcept C185592680 @default.
• W2801236435 hasConcept C2775986502 @default.
• W2801236435 hasConcept C31827203 @default.
• W2801236435 hasConcept C40684141 @default.
• W2801236435 hasConcept C43617362 @default.
• W2801236435 hasConcept C64489805 @default.
• W2801236435 hasConcept C71043704 @default.
• W2801236435 hasConcept C74774607 @default.
• W2801236435 hasConceptScore W2801236435C119128265 @default.
• W2801236435 hasConceptScore W2801236435C162356407 @default.
• W2801236435 hasConceptScore W2801236435C185592680 @default.
• W2801236435 hasConceptScore W2801236435C2775986502 @default.
• W2801236435 hasConceptScore W2801236435C31827203 @default.
• W2801236435 hasConceptScore W2801236435C40684141 @default.
• W2801236435 hasConceptScore W2801236435C43617362 @default.
• W2801236435 hasConceptScore W2801236435C64489805 @default.
• W2801236435 hasConceptScore W2801236435C71043704 @default.
• W2801236435 hasConceptScore W2801236435C74774607 @default.
• W2801236435 hasFunder F4320321006 @default.
• W2801236435 hasFunder F4320324127 @default.
• W2801236435 hasLocation W28012364351 @default.
• W2801236435 hasLocation W28012364352 @default.
• W2801236435 hasOpenAccess W2801236435 @default.
• W2801236435 hasPrimaryLocation W28012364351 @default.
• W2801236435 hasRelatedWork W1967724306 @default.
• W2801236435 hasRelatedWork W2029154389 @default.
• W2801236435 hasRelatedWork W2067330529 @default.
• W2801236435 hasRelatedWork W2088766582 @default.
• W2801236435 hasRelatedWork W2145540723 @default.
• W2801236435 hasRelatedWork W2155162252 @default.
• W2801236435 hasRelatedWork W2355511169 @default.
• W2801236435 hasRelatedWork W3015973421 @default.
• W2801236435 hasRelatedWork W3143827393 @default.
• W2801236435 hasRelatedWork W3195329777 @default.
• W2801236435 hasVolume "1089" @default.
• W2801236435 isParatext "false" @default.
• W2801236435 isRetracted "false" @default.
• W2801236435 magId "2801236435" @default.
• W2801236435 workType "article" @default.